TASLY MYASTRA PILLS
TASLY MYASTRA PILLS : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Dalbergia odorifera | Dalbergia odorifera[5.71 mg,520 mg] | Not identified |
| Panax notoginseng | Panax notoginseng[85.71 mg,520 mg] | Not identified |
| Salvia miltiorrhiza | Salvia miltiorrhiza[428.57 mg,520 mg] | Not identified |
| Astragalus membranaceus | Astragalus membranaceus[857.14 mg,520 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL20066133T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- TASLY (MALAYSIA) SDN. BHD.
- Manufacturer
- TASLY PHARMACEUTICAL GROUP CO., LTD.
- Importer
- TASLY (MALAYSIA) SDN. BHD.
- Registration period starting
- 2025-06-24
- Published validity end
- 2030-06-24
Original register data
View published fields and their variants
- Active ingredients
- Dalbergia odorifera[5.71 mg,520 mg],Panax notoginseng[85.71 mg,520 mg],Salvia miltiorrhiza[428.57 mg,520 mg],Astragalus membranaceus[857.14 mg,520 mg]
- Valid until
- 2030-06-24
- Registration date
- 2025-06-24
- Published description
- NATURAL PRODUCT
- Licence holder
- TASLY (MALAYSIA) SDN. BHD.
- Importer
- TASLY (MALAYSIA) SDN. BHD.
- Producer
- TASLY PHARMACEUTICAL GROUP CO., LTD.
- Published name
- TASLY MYASTRA PILLS
- Published reference
- 201911273032T
- Registration number
- MAL20066133T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL20066133T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Astragalus membranaceus
Read the warning, when it applies and the studies cited
ASTRAGALUS - ASTRAGALUS MEMBRANACEUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).
Sources cited by Health Canada (2)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “TASLY MYASTRA PILLS”, https://compoatlas.com/en/supplements/malaysia/MAL20066133T-tasly-myastra-pills, updated 27 October 2026.